Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: SAFIR02_Lung - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Non-small Cell Lung Cancer

NCT02117167 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT02117167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: SAFIR02_Lung - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Non-small Cell Lung Cancer
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
April 23, 2014
Completion date
December 31, 2023
Enrollment
999 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer metastatic